Novozymes Sues Danisco Over New Enzyme Patent

Law360, New York (May 12, 2010, 4:39 PM EDT) -- Danish biopharmaceutical company Novozymes A/S has wasted no time asserting its newest patent covering a variant of the enzyme alpha amylase, accusing rival Danisco A/S of infringing the patent the same day it was issued.

The suit, filed Tuesday in the U.S. District Court for the Western District of Wisconsin, accuses Danisco of directly infringing one or more claims of the patent-in-suit by making, using, offering to sell and/ or selling alpha amylase products that embody the invention.

The patent — U.S. Patent Number 7,713,723, titled...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.